Mitoquinone mesylate

non-nutrient/non-botanical

What is it

Mitoquinone mesylate, commonly known as MitoQ, is a synthetic compound that combines coenzyme Q10 (CoQ10) with a triphenylphosphonium (TPP) lipophilic cation. This modification allows it to accumulate specifically inside mitochondria, where it acts as a targeted antioxidant. It is sold as a dietary supplement for general health and is also studied for various conditions.

How it works

The TPP cation of MitoQ allows the molecule to be drawn into mitochondria, where the inner membrane's negative charge concentrates it several hundred-fold compared with cytosol. Inside mitochondria, it is reduced to the active ubiquinol form, which scavenges reactive oxygen species generated by the electron transport chain. After scavenging, it is regenerated by the electron transport chain to repeat its action. This targeted delivery is the main difference from standard CoQ10, which has limited mitochondrial accumulation. Animal and laboratory studies have shown protective effects in many conditions involving mitochondrial oxidative stress, including aging, cardiovascular disease, and neurodegeneration. Human clinical trials are growing but still limited.

Evidence for 5 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Vascular function in middle-aged and older adults

Grade B

Good evidence

Small randomized trials have shown improvements in endothelial function (flow-mediated dilation) and reductions in arterial stiffness in middle-aged and older adults with MitoQ supplementation. This is among the more robust human evidence.

Mitochondrial dysfunction / oxidative stress

Grade C

Moderate evidence

Studies in chronic kidney disease and other conditions have shown reductions in oxidative stress markers with MitoQ supplementation. Clinical relevance to disease outcomes is still being studied.

General antioxidant / anti-aging

Grade C

Moderate evidence

MitoQ has shown reductions in markers of oxidative stress and inflammation in various populations. Whether this translates to long-term aging benefits in humans is unknown.

Exercise / fatigue

Grade D

Mixed evidence

Limited studies have examined effects on exercise performance and fatigue. Results are preliminary.

Neurodegenerative protection

Grade F

Limited evidence

Animal studies suggest neuroprotection in models of Parkinson's, Alzheimer's, and stroke. Human clinical evidence for neuroprotective effects is limited.

1 commercial form

MitoQ (mitoquinone mesylate) capsules

Mitochondria-targeted via lipophilic cation

The standard commercial form. Typically 10 mg per capsule.

Dosage

Most clinical trials and supplements use 5-20 mg of MitoQ per day. Higher doses have been tested in some clinical trials. The 10 mg per day dose is a common commercial standard.

When and how to take it

Most clinical trials have used MitoQ taken once daily, often in the morning on an empty stomach or with light food. Some sources recommend taking on an empty stomach to maximize absorption. There is no compelling evidence for specific timing relative to other medications or supplements.

Safety

Generally well tolerated at the doses used in clinical trials. Possible side effects include nausea, mild gastrointestinal upset, and (rarely) skin reactions. Long-term safety data are limited but accumulating. Acute toxicity at very high doses has been reported in animal studies due to the lipophilic cation accumulating in mitochondria.

Who should be cautious

Insufficient data for pregnancy and breastfeeding; avoid or consult a clinician. People taking warfarin or other anticoagulants should monitor INR. Those with cardiovascular disease, on chemotherapy, or with serious medical conditions should consult a clinician before use.

Interactions

MitoQ has not been extensively studied for drug interactions. Theoretical interactions may exist with statins (which can deplete CoQ10), anticoagulants (CoQ10 may slightly reduce warfarin effects), antihypertensives, and chemotherapy agents (antioxidant interactions). Consult a clinician if on prescription medications.

Frequently asked questions

How is MitoQ different from CoQ10?⌄

MitoQ has a positively charged 'tail' that accumulates inside mitochondria 100-1000 times more concentrated than CoQ10. Doses are much lower (mg vs. hundreds of mg for CoQ10).

Is MitoQ better than CoQ10?⌄

It targets mitochondria more directly, but human clinical evidence is still developing. They serve somewhat different roles and direct comparisons are limited.

Will MitoQ help me feel less tired?⌄

Some studies suggest benefits for fatigue in certain conditions, but evidence in healthy people is preliminary.

Should I take MitoQ with food?⌄

Most clinical studies have used it on an empty stomach or with light food. There is no strong evidence for or against either approach.

Is MitoQ safe long-term?⌄

Short-term clinical data look favorable. Long-term human safety data are still accumulating. At standard supplement doses (10 mg/day), the safety profile appears good.

References

  • Mitoquinone (Wikidata) — Wikidata link
  • Mitoquinone (PubChem CID 11388331) — PubChem link
  • Mitoquinone (ChEBI 234429) — ChEBI link

Track Mitoquinone mesylate with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition.